Annual EBITDA
-$1.57 M
NaN%
December 31, 2021
Summary
- As of February 9, 2025, BIOT annual EBITDA is -$1.57 million
Performance
BIOT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$246.60 K
+$1.02 M+80.50%
September 30, 2022
Summary
- As of February 9, 2025, BIOT quarterly EBITDA is -$246.60 thousand, with the most recent change of +$1.02 million (+80.50%) on September 30, 2022.
- Over the past year, BIOT quarterly EBITDA has increased by +$383.30 thousand (+60.85%).
Performance
BIOT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$3.74 M
+$383.30 K+9.30%
September 30, 2022
Summary
- As of February 9, 2025, BIOT TTM EBITDA is -$3.74 million, with the most recent change of +$383.30 thousand (+9.30%) on September 30, 2022.
- Over the past year, BIOT TTM EBITDA has dropped by -$2.50 million (-201.39%).
Performance
BIOT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BIOT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +60.9% | -201.4% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
BIOT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | +669.3% | +138.1% | +10.3% |
| 5 y | 5-year | at high | at low | +67.6% | +669.3% | +2441.3% | +10.3% |
| alltime | all time | at high | at low | +67.6% | +669.3% | +2441.3% | +10.3% |
Biotech Acquisition EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$246.60 K(-80.5%) | -$3.74 M(-9.3%) |
| Jun 2022 | - | -$1.26 M(-33.3%) | -$4.12 M(+24.1%) |
| Mar 2022 | - | -$1.90 M(+474.9%) | -$3.32 M(+111.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$1.57 M | -$330.00 K(-47.6%) | -$1.57 M(+26.6%) |
| Sep 2021 | - | -$629.90 K(+36.0%) | -$1.24 M(+103.2%) |
| Jun 2021 | - | -$463.30 K(+215.0%) | -$610.40 K(+315.0%) |
| Mar 2021 | - | -$147.10 K | -$147.10 K |
FAQ
- What is Biotech Acquisition annual EBITDA?
- What is the all time high annual EBITDA for Biotech Acquisition?
- What is Biotech Acquisition quarterly EBITDA?
- What is the all time high quarterly EBITDA for Biotech Acquisition?
- What is Biotech Acquisition quarterly EBITDA year-on-year change?
- What is Biotech Acquisition TTM EBITDA?
- What is the all time high TTM EBITDA for Biotech Acquisition?
- What is Biotech Acquisition TTM EBITDA year-on-year change?
What is Biotech Acquisition annual EBITDA?
The current annual EBITDA of BIOT is -$1.57 M
What is the all time high annual EBITDA for Biotech Acquisition?
Biotech Acquisition all-time high annual EBITDA is -$1.57 M
What is Biotech Acquisition quarterly EBITDA?
The current quarterly EBITDA of BIOT is -$246.60 K
What is the all time high quarterly EBITDA for Biotech Acquisition?
Biotech Acquisition all-time high quarterly EBITDA is -$147.10 K
What is Biotech Acquisition quarterly EBITDA year-on-year change?
Over the past year, BIOT quarterly EBITDA has changed by +$383.30 K (+60.85%)
What is Biotech Acquisition TTM EBITDA?
The current TTM EBITDA of BIOT is -$3.74 M
What is the all time high TTM EBITDA for Biotech Acquisition?
Biotech Acquisition all-time high TTM EBITDA is -$147.10 K
What is Biotech Acquisition TTM EBITDA year-on-year change?
Over the past year, BIOT TTM EBITDA has changed by -$2.50 M (-201.39%)